The Economic Times

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Molbio Diagnostics IPO entered its final bidding day with strong demand, with the Rs 939.70-crore issue subscribed 4.91 times. Its GMP has risen to 17.1%, signalling expectations of a strong listing. The IPO comprises a Rs 200-crore fresh issue and a Rs 739.70-crore OFS.